TY - JOUR JO - EuroIntervention TI - Contemporary parenteral antiplatelet bridging strategies: a single-centre real-world experience at a tertiary care centre AB - <p class="text-1er-paragraph">Oral antiplatelet therapy may require temporary disruption soon after percutaneous coronary intervention (PCI) or acute coronary syndrome, incurring potential thrombotic risks. Glycoprotein IIb/IIIa inhibitors have been used AU - Stern Gretchen M. AU - Rimsans Jessica AU - Qamar Arman AU - Vaduganathan Muthiah AU - Bhatt L. Deepak VL - 14 IS - 3 Y1 - 14/06/2018 Y1 - 2018 DOI - 10.4244/EIJ-D-18-00036 SP - e333 EP - e335 PB - Europa Digital & Publishing SE - CORONARY INTERVENTIONS UR - https://eurointervention.pcronline.com/article/contemporary-parenteral-antiplatelet-bridging-strategies-a-single-centre-real-world-experience-at-a-tertiary-care-centre SN - 1774-024X ER -